ABBV Message Board Post 8922840 | AbbVie Inc.
home / stock / abbv / abbv message board
Gravity
(investorshub)
Posted on: Oct/28/2022 13:26:40
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170311233
$ABBV 3Q22 results:
News, Short Squeeze, Breakout and More Instantly...
-
On Thursday, Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Eve...
-
2024-04-26 16:07:11 ET By almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant delivered first-quarter sales and earnings results that topped estimates. The decline in sales of multi-indication immunosuppressive drug Humira -- a natural r...
-
2024-04-26 15:15:13 ET Image source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: AbbVie (ABBV) Q1 2024 Earnings Call Transcript